{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:21:25Z","timestamp":1789662085868,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.farma.2025.06.013","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T19:30:10Z","timestamp":1753817410000},"page":"97-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["In vitro assay of pharmacobezoar formation with extended-release divalproex sodium tablets"],"prefix":"10.1016","volume":"50","author":[{"given":"Thais Lizondo","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Gonz\u00e1lez","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"L\u00f3pez-Cabezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit Julian","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naira Rico","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors Soy","family":"Muner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria Fern\u00e1ndez","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio Salgado","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.farma.2025.06.013_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2022.0313","article-title":"Toxicology in the emergency department: what's new?","volume":"83","author":"Motohashi","year":"2022","journal-title":"Br J Hosp Med"},{"key":"10.1016\/j.farma.2025.06.013_bb0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.14740\/gr871w","article-title":"Pharmacobezoar: an unusual cause of large bowel obstruction","volume":"10","author":"Yelisetti","year":"2017","journal-title":"Gastroenterol Res"},{"key":"10.1016\/j.farma.2025.06.013_bb0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/15563650.2018.1513138","article-title":"Potential pharmacobezoar formation of large size extended-release tablets and their dissolution \u2013 an in vitro study","volume":"57","author":"Hoegberg","year":"2019","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.farma.2025.06.013_bb0020","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3109\/15563650.2011.565420","article-title":"Pharmacobezoar of the esophagus","volume":"49","author":"Liaw","year":"2011","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.farma.2025.06.013_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13256-019-1984-0","article-title":"Endoscopic removal of a gastric pharmacobezoar induced by clomipramine, lorazepam, and domperidone overdose: a case report","volume":"13","author":"von D\u00fcring","year":"2019","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.farma.2025.06.013_bb0030","first-page":"175","article-title":"The role of oral controlled release matrix tablets in drug delivery systems","volume":"2","author":"Nokhodchi","year":"2012","journal-title":"Bioimpacts"},{"key":"10.1016\/j.farma.2025.06.013_bb0035","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s12024-021-00404-x","article-title":"Gastro-esophageal pharmacobezoar","volume":"17","author":"Byard","year":"2021","journal-title":"Forensic Sci Med Pathol"},{"key":"10.1016\/j.farma.2025.06.013_bb0136","series-title":"Goldfrank\u2019s Toxicologic Emergencies, 11e","article-title":"Techniques Used to Prevent Gastrointestinal Absorption","author":"Hoegberg","year":"2019"},{"key":"10.1016\/j.farma.2025.06.013_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00002018-199512010-00006","article-title":"Controlled release drugs in overdose clinical considerations","volume":"12","author":"Buckley","year":"1995","journal-title":"Drug Saf"},{"key":"10.1016\/j.farma.2025.06.013_bb0050","author":"Centro de informaci\u00f3n de medicamentos (CIMA). Depakine Crono\u00ae (Divalproex sodium). Spain. Sanofi-Aventis, S.A"},{"key":"10.1016\/j.farma.2025.06.013_bb0055","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jemermed.2022.07.009","article-title":"Valproic acid overdose: case report and literature review","volume":"63","author":"Patel","year":"2022","journal-title":"J Emerg Med"},{"key":"10.1016\/j.farma.2025.06.013_bb0060","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE commission on therapeutic strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.farma.2025.06.013_bb0065","series-title":"Simulated gastric fluid","author":"Pharmacopoeia Europea","year":"2022"},{"key":"10.1016\/j.farma.2025.06.013_bb0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/15563650902752376","article-title":"Carnitine in the treatment of valproic acid-induced toxicity","volume":"47","author":"Lheureux","year":"2009","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.farma.2025.06.013_bb0075","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1067\/mem.2002.124443","article-title":"Delayed valproic acid toxicity: a retrospective case series","volume":"39","author":"Ingels","year":"2002","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.farma.2025.06.013_bb0080","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5694\/j.1326-5377.2008.tb01629.x","article-title":"Prolonged absorption and delayed peak paracetamol concentration following poisoning with extended-release formulation","volume":"188","author":"Roberts","year":"2018","journal-title":"Med J Aust"},{"key":"10.1016\/j.farma.2025.06.013_bb0085","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1080\/15563650.2019.1705971","article-title":"In vitro study of pharmacobezoar formation in simulated acetaminophen overdose","volume":"58","author":"Li","year":"2020","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.farma.2025.06.013_bb0090","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1592\/phco.26.12.1802","article-title":"Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine","volume":"26","author":"Wells","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.farma.2025.06.013_bb0095","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/15563650701517731","article-title":"Gastric bezoar following venlafaxine overdose","volume":"45","author":"Djogovic","year":"2007","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.farma.2025.06.013_bb0100","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3109\/15563650.2013.856442","article-title":"Gastric pharmacobezoars in quetiapine extended-release overdose: a case series","volume":"51","author":"Rauber-L\u00fcthy","year":"2013","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.farma.2025.06.013_bb0105","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.forsciint.2013.03.025","article-title":"Suicidal overdose with relapsing clomipramine concentrations due to a large gastric pharmacobezoar","volume":"229","author":"Magdalan","year":"2013","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.farma.2025.06.013_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7456242","article-title":"The combination therapy of dissolution using carbonated liquid and endoscopic procedure for bezoars: pragmatical and clinical review","author":"Ogawa","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.farma.2025.06.013_bb0115","first-page":"245","article-title":"Dissolution of pharmacobezoar using carbonated beverage","volume":"27","author":"Harikumar","year":"2008","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.farma.2025.06.013_bb0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jemermed.2013.08.031","article-title":"Endoscopic removal of pharmacobezoar in case of intentional potassium overdose","volume":"46","author":"Briggs","year":"2014","journal-title":"J Emerg Med"},{"key":"10.1016\/j.farma.2025.06.013_bb0125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.toxrep.2014.04.002","article-title":"Extended release potassium salts overdose and endoscopic removal of a pharmacobezoar: a case report","volume":"1","author":"Guillermo","year":"2014","journal-title":"Toxicol Rep"},{"key":"10.1016\/j.farma.2025.06.013_bb0130","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/bmj.293.6555.1143","article-title":"Endoscopic removal of pharmacobezoar of slow release theophylline","volume":"293","author":"Cereda","year":"1986","journal-title":"BMJ"},{"key":"10.1016\/j.farma.2025.06.013_bb0135","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s00595-009-4158-7","article-title":"Rectal obstruction by a giant pharmacobezoar composed of magnesium oxide: report of a case","volume":"40","author":"Shigekawa","year":"2010","journal-title":"Surg Today"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634325001035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634325001035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:39:44Z","timestamp":1773351584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634325001035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1130634325001035"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2025.06.013","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro assay of pharmacobezoar formation with extended-release divalproex sodium tablets","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2025.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H).","name":"copyright","label":"Copyright"}]}}